Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial) https://www.nature.com/articles/s41598-024-59621-3
Discover the world at Altruu, The Discovery Engine